Eurofins MWG Operon Launches Sequencing Service on PacBio RS System
Consistent with its pioneering initiatives, Eurofins MWG Operon has now included the new sequencing platform PacBio RS into its portfolio, further expanding its technological platform available for next generation sequencing services.
“We take specific care to build up a technical and operational pipeline which is suitable to meet our quality standards and the high service level we want to provide to our customers”, says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. “After our evaluation of PacBio RS, we believe that the platform is one of the most promising new NGS technologies on the market. Our team has extensively tested the system using selected bacterial, fungal and higher plant genomes. The most recent technical updates on this machine give way to strobe-sequencing and enable delivery of reads longer than 1500 bp to 2500 bp in a range of more than 10%, while some reads are already longer than 4500 bp. Using this technique, we can develop and offer new strategies to our customers for faster, cheaper and more accurate sequencing of complex genomic data sets.”
Eurofins Genomics GmbH
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in Europe, the United States, and Asia, is an international provider of DNA sequencing services, DNA synthesis products and bioinformatic services for academic and industrial research. As one of the first service providers for next generation sequencing, Eurofins MWG Operon has established profound know-how and proprietary protocols to cover a broad range of applications. The company’s strength is its strong customer orientation, fast service, and high quality. For further information, please visit our website at: www.eurofinsdna.com